SE7507726L - Forfarande for framstellning av hydroxialkylxantiner. - Google Patents

Forfarande for framstellning av hydroxialkylxantiner.

Info

Publication number
SE7507726L
SE7507726L SE7507726A SE7507726A SE7507726L SE 7507726 L SE7507726 L SE 7507726L SE 7507726 A SE7507726 A SE 7507726A SE 7507726 A SE7507726 A SE 7507726A SE 7507726 L SE7507726 L SE 7507726L
Authority
SE
Sweden
Prior art keywords
atoms
prepared
radicals
preparation
monoalkenyldialkylxanthines
Prior art date
Application number
SE7507726A
Other languages
English (en)
Other versions
SE420097B (sv
Inventor
A Soder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7507726L publication Critical patent/SE7507726L/sv
Publication of SE420097B publication Critical patent/SE420097B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7507726A 1974-07-05 1975-07-04 Forfarande for framstellning av hydroxialkylxantiner SE420097B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (2)

Publication Number Publication Date
SE7507726L true SE7507726L (sv) 1976-01-07
SE420097B SE420097B (sv) 1981-09-14

Family

ID=27048497

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7507726A SE420097B (sv) 1974-07-05 1975-07-04 Forfarande for framstellning av hydroxialkylxantiner
SE7807853A SE427183B (sv) 1974-07-05 1978-07-14 Mono-(alken-1-yl)-xantiner till anvendning sasom mellanprodukter vid framstellning av terapeutiskt verdefulla hydroxialkylxantinforeningar

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7807853A SE427183B (sv) 1974-07-05 1978-07-14 Mono-(alken-1-yl)-xantiner till anvendning sasom mellanprodukter vid framstellning av terapeutiskt verdefulla hydroxialkylxantinforeningar

Country Status (14)

Country Link
JP (1) JPS5250800B2 (sv)
AR (1) AR210330A1 (sv)
AT (1) AT339917B (sv)
CA (1) CA1062710A (sv)
CH (2) CH622519A5 (sv)
DK (1) DK140214B (sv)
ES (1) ES439141A1 (sv)
FI (1) FI59249C (sv)
FR (1) FR2277089A1 (sv)
GB (1) GB1500039A (sv)
LU (1) LU72897A1 (sv)
NL (1) NL166476C (sv)
NO (1) NO143224C (sv)
SE (2) SE420097B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
DK140214C (sv) 1979-12-03
NO143224C (no) 1981-01-02
SE427183B (sv) 1983-03-14
FI59249B (fi) 1981-03-31
NL7507976A (nl) 1976-01-07
NO752423L (sv) 1976-01-06
CA1062710A (en) 1979-09-18
FI751958A (sv) 1976-01-06
ATA517275A (de) 1977-03-15
DK140214B (da) 1979-07-09
GB1500039A (en) 1978-02-08
NL166476C (nl) 1981-08-17
CH622018A5 (en) 1981-03-13
FR2277089A1 (fr) 1976-01-30
FR2277089B1 (sv) 1978-03-17
NL166476B (nl) 1981-03-16
DK301775A (sv) 1976-01-06
AU8275575A (en) 1977-01-06
AR210330A1 (es) 1977-07-29
JPS5250800B2 (sv) 1977-12-27
CH622519A5 (en) 1981-04-15
NO143224B (no) 1980-09-22
LU72897A1 (sv) 1976-05-31
ES439141A1 (es) 1977-02-16
JPS5134194A (sv) 1976-03-23
SE420097B (sv) 1981-09-14
AT339917B (de) 1977-11-10
FI59249C (fi) 1981-07-10
SE7807853L (sv) 1978-07-14

Similar Documents

Publication Publication Date Title
DE3468869D1 (en) Substituted 2-mercapto-imidazoles and their preparation and use
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
UA7228A1 (uk) Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
ES437997A1 (es) Procedimiento de preparacion de compuestos opacificantes pa-ra radiografia y similares.
NO165921C (no) Fremgangsmaate for fremstilling av disubstituerte prolinderivater.
CH614448A5 (en) Process for the preparation of novel tertiary amines and their acid addition salts, and compounds thus prepared
SE7507726L (sv) Forfarande for framstellning av hydroxialkylxantiner.
FR2358141A1 (fr) Nouveaux anesthesiques locaux
ATE25666T1 (de) Verfahren zur herstellung von diaminoalkoholen.
ES378824A1 (es) Procedimiento para la preparacion de lactonas de acido hi- droxicrotonico.
FR2359832A1 (fr) 1,3,5-tris-(2-chloroformyl-oxyethyl)-isocyanurate
SE7714656L (sv) Sulfamoylbensoesyror
ATE35261T1 (de) 4-ethyl-2-hydroxy-3-methyl-2-phenylmorpholin und dessen additionssalze.
ES399003A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas-(2) sustituidas.
GB845486A (en) Improvements in or relating to 2-diarylalkyl-3,4,5,6-tetrahydropyrimidines
ES365218A1 (es) Procedimiento para la obtencion de beta-alcoxiacrilamidas.
GB1325944A (en) Bisoxalic acid diamides
GB1522537A (en) 2,4-diamino-5-benzylpyrimidines
GB1540049A (en) 9,11-bridged prostaglandins
ATE29253T1 (de) Verfahren zur herstellung von 4-chinolinonen.
ES428968A1 (es) Procedimiento para la preparacion de 1, 2, 2, 2-tetrafluo- raltil-eteres.
ATE24899T1 (de) Verfahren zur herstellung von 4-quinolinonen.
ES398232A1 (es) Un procedimiento para la preparacion de esteres de acido indenilacetico sustituido.
ES428624A1 (es) Procedimiento para la preparacion de derivados de la pirimi-dina.
CH623443GA3 (en) Process for the preparation of stilbene compounds and their use as optical brighteners

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7507726-3

Effective date: 19940210

Format of ref document f/p: F